Close menu




December 20th, 2024 | 08:00 CET

CAUTION advised for Rheinmetall! COMEBACK for Bayer and Saturn Oil + Gas?

  • Mining
  • Oil
  • Defense
  • Pharma
Photo credits: pixabay.com

Christmas came a week early for Rheinmetall. Germany's largest defense company has secured further orders worth EUR 1.7 billion. However, investors are reacting cautiously, as a slump could be imminent. In contrast, the downside risk for Saturn Oil & Gas appears limited, with significant upside potential. As one of North America's most cost-effective oil producers, Saturn aims to generate total free cash flow of up to CAD 475 million over three years. Analysts’ targets represent a tripling of the share price. And what is Bayer doing? The Leverkusen-based company is trading close to its multi-year low. However, one analyst outlines an interesting scenario.

time to read: 3 minutes | Author: Fabian Lorenz
ISIN: RHEINMETALL AG | DE0007030009 , BAYER AG NA O.N. | DE000BAY0017 , Saturn Oil + Gas Inc. | CA80412L8832

Table of contents:


    Saturn Oil & Gas: An estimated 475 million in free cash flow over three years!

    Although 2024 showed that fossil fuels will be needed for a long time to come, it was a challenging year for stocks in the sector. Even industry leader Exxon Mobile clearly underperformed the Dow Jones and S&P 500. However, the losers of one year are often the winners of the next. One candidate for this is the stock of Saturn Oil & Gas. Since 2021, Saturn has completed four transformative acquisitions, propelling it to a mid-tier producer.

    Just a few days ago, Saturn Oil & Gas published its 2025 annual forecast and a medium-term outlook. If the plans are implemented as announced, the share price – which is also actively traded in Germany – could be poised for a rerate. In 2025, the Company aims to maintain stable production at an average of 38,000 to 40,000 barrels of oil equivalent per day. With this, the Company aims to achieve an impressive free cash flow of CAD 125 to CAD 165 million. This would translate to CAD 0.65 to CAD 0.85 per share. Saturn’s shares are currently trading at CAD 2. The free cash flow will be used, among other things, for the agreed share buyback program, the reduction of net debt to between CAD 700 million and CAD 740 million, and opportunistic acquisitions.

    The medium-term key data is also convincing: A cumulative free cash flow of CAD 450 to 475 million is forecast to be generated between 2025 and 2027. This would equate to at least CAD 2.34 per share based on forecast exit 2025 shares outstanding. At an oil price (WTI) of USD 80 and higher, it could also be more. In this context, the target price of CAD 6.50 set by the analyst at Ventum for the Saturn share seems anything but high.

    Rheinmetall: Caution despite billion-euro orders

    Unlike Saturn Oil & Gas, Rheinmetall's stock is no longer a bargain. However, the shares of Germany's largest defense company have more than doubled in the current year. And business continues to boom. Just yesterday, Rheinmetall received two orders worth EUR 1.7 billion from the German government for the digitization of the Bundeswehr.

    Together with KNDS, Rheinmetall is to equip around 10,000 Bundeswehr vehicles with new digital communications systems. The two partners will receive EUR 1.98 billion over the next six years, which they will divide equally between them. The second order is for IT systems to be integrated into all vehicle and platform systems of the land forces. Of the order volume of EUR 730 million, EUR 470 million will go to Rheinmetall and EUR 250 million to its partner blackned.

    Nevertheless, the share price of the Düsseldorf-based company rose 'only' by around 1%. On the one hand, the share had already performed very well. However, the possible end of the war in Ukraine following the inauguration of Donald Trump in the US could deter investors from buying the stock. Even if Rheinmetall continues to benefit from the arms build-up in Europe and beyond in the coming years, the end of the war should cause a sharp correction in the share price – how long this lasts remains to be seen.

    Bayer: Beneficiary of a potential end to the war?

    Could Bayer shares be among the winners if the war in Ukraine ends? This is the scenario outlined by UBS. Accordingly, they suggest that a ceasefire with Russia could lead to increased gas flows to Germany. Like other chemical companies and energy-intensive industries, Bayer would stand to benefit. But for now, uncertainty remains. Therefore, the UBS analysts maintain a 'Neutral' rating with a target price of EUR 22.

    While Rheinmetall's shares are among the high flyers of 2024, Bayer's shares are among the disappointments – again. Around 45% of the Leverkusen-based company's shares have been lost this year. The reason for this is the ongoing court cases in the US. These simply do not seem to be coming to an end. However, UBS outlines a scenario that could benefit Bayer.


    Saturn Oil & Gas's stock seems to be anything but expensive at the current price level. The Canadians have developed into a strong oil producer within a few years and aim to increase their high free cash flow further. A comeback for the stock in 2025 seems entirely realistic. Rheinmetall's shares have performed strongly in 2024 and over the past three years. It is not surprising that investors are cautious in light of the new US president. Bayer seems to have bottomed out. However, there is still a lack of upside potential.


    Conflict of interest

    Pursuant to §85 of the German Securities Trading Act (WpHG), we point out that Apaton Finance GmbH as well as partners, authors or employees of Apaton Finance GmbH (hereinafter referred to as "Relevant Persons") may hold shares or other financial instruments of the aforementioned companies in the future or may bet on rising or falling prices and thus a conflict of interest may arise in the future. The Relevant Persons reserve the right to buy or sell shares or other financial instruments of the Company at any time (hereinafter each a "Transaction"). Transactions may, under certain circumstances, influence the respective price of the shares or other financial instruments of the Company.

    In addition, Apaton Finance GmbH is active in the context of the preparation and publication of the reporting in paid contractual relationships.

    For this reason, there is a concrete conflict of interest.

    The above information on existing conflicts of interest applies to all types and forms of publication used by Apaton Finance GmbH for publications on companies.

    Risk notice

    Apaton Finance GmbH offers editors, agencies and companies the opportunity to publish commentaries, interviews, summaries, news and the like on news.financial. These contents are exclusively for the information of the readers and do not represent any call to action or recommendations, neither explicitly nor implicitly they are to be understood as an assurance of possible price developments. The contents do not replace individual expert investment advice and do not constitute an offer to sell the discussed share(s) or other financial instruments, nor an invitation to buy or sell such.

    The content is expressly not a financial analysis, but a journalistic or advertising text. Readers or users who make investment decisions or carry out transactions on the basis of the information provided here do so entirely at their own risk. No contractual relationship is established between Apaton Finance GmbH and its readers or the users of its offers, as our information only refers to the company and not to the investment decision of the reader or user.

    The acquisition of financial instruments involves high risks, which can lead to the total loss of the invested capital. The information published by Apaton Finance GmbH and its authors is based on careful research. Nevertheless, no liability is assumed for financial losses or a content-related guarantee for the topicality, correctness, appropriateness and completeness of the content provided here. Please also note our Terms of use.


    Der Autor

    Fabian Lorenz

    For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.

    About the author



    Related comments:

    Commented by Nico Popp on March 30th, 2026 | 08:30 CEST

    A Paradigm Shift in Oncology: Core Stocks Roche & Galderma and the High-Leverage Opportunity in Vidac Pharma

    • Biotechnology
    • Biotech
    • Pharma
    • Innovations
    • Cancer

    Medical advances affect us all. Oncology is also undergoing a transformation. As conventional immunotherapies for skin cancer increasingly reach their limits, clinical research is shifting its focus to correcting defective tumor metabolism. The Warburg effect, where cancer cells shift energy production to aerobic glycolysis to fuel uncontrolled growth, offers a promising entry point. This dynamic development landscape is exacerbated by an impending patent cliff, which, according to calculations by the consulting firm PwC, threatens industry revenues of USD 104 billion by 2028, as many patents for active ingredients are expiring. Currently, market researchers at Fortune Business Insights estimate the volume of the global oncology market for 2026 at USD 286.36 billion. While pharmaceutical giant Roche secures its market leadership and the Galderma Group dominates standard dermatological care, biotechnology company Vidac Pharma is targeting the metabolic vulnerability of cancer cells with a completely novel mechanism of action, aiming to effectively shut down the cancer.

    Read

    Commented by André Will-Laudien on March 30th, 2026 | 08:25 CEST

    NEO Battery Materials Charging Ahead – The New Performance Standard for the Energy of the Future

    • Batteries
    • BatteryMetals
    • Defense
    • Drones
    • hightech

    While the Iran conflict in the Middle East is unsettling the global economy, a much deeper shift in the balance of power is taking place on the global commodities market. The rivalry between the US and China, long marked by trade and technology wars, is now extending to energy supply and battery production. Beijing is restricting not only the export of rare earths but also the export of high-performance battery cells, forcing Western industries to reorganize their supply chains. The situation is particularly critical for batteries used in defense and drone technology, which are considered security-critical infrastructure. The general public's thinking is simple: with the constant rise in the cost of fossil fuels, the world faces a choice - accept expensive mobility or pursue self-sufficient development of renewable solutions! In this context, the Canadian-South Korean company NEO Battery Materials is making a strategic statement of technological independence.

    Read

    Commented by Stefan Feulner on March 30th, 2026 | 08:15 CEST

    Pan American Silver, Silver North Resources, Agnico Eagle – Long-Term Trend Intact

    • Mining
    • Silver
    • Commodities
    • geopolitics
    • photovoltaics
    • Defense

    Following the recent correction in the silver market, there are increasing indications that the pullback represents a consolidation within a broader structural uptrend rather than a trend reversal. Demand from photovoltaics, electric mobility, and defense applications remains robust, while supply growth continues to lag. At the same time, geopolitical uncertainty and potential interest rate cuts are providing additional tailwinds. Historically, sharp corrections have often been followed by strong upward movements. For long-term investors, an attractive entry window may currently be opening.

    Read